Complete resolution of posttransplant lymphoproliferative disorder (diffuse large B-cell lymphoma) with reduction of immunosuppressive therapy

被引:3
|
作者
Ryu, HJ
Hahn, JS
Kim, YS
Park, K
Yang, WI
Lee, JD
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea
[4] Yonsei Univ, Coll Med, Dept Radiol, Seoul 120752, South Korea
关键词
PTLD; immunosuppression; reduction; resolution;
D O I
10.3349/ymj.2004.45.3.527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantation. PTLD is the disorder arising from the combined effects of Epstein-Barr virus associated lymphoid proliferation with the disruption of the normal immune control by the cytotoxic T cells. The treatment for PTLD is one of the most controversial topics in solid organ transplantation. It is well known that the initial management of PTLD is a reduction of immunosuppression. Early diagnosis and the early reduction in immunosuppression are essential even for monomorphic lymphoma. We report here on a case of the complete resolution of PTLD (diffuse large B cell lymphoma) which occurred after a drastic reduction of immunosuppression in a renal transplant recipient.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [21] Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape
    Su, Xiuhua
    Sun, Tao
    Li, Meng
    Xia, Yuan
    Li, Mingying
    Wang, Dongmei
    Lu, Fei
    Ye, Jingjing
    Ji, Chunyan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [22] Neuroinvasive Seronegative West Nile Virus in the Setting of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma
    Yuen, Alexander D.
    Liu, Jason Y.
    Betancourt, Jaime
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (06) : E85 - E87
  • [23] Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma
    Li, Xiaoqian
    Sun, Xun
    Li, Juan
    Liu, Zijian
    Mi, Mi
    Zhu, Fang
    Wu, Gang
    Lan, Xiaoli
    Zhang, Liling
    CANCER MEDICINE, 2019, 8 (11): : 5012 - 5022
  • [24] Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape
    Xiuhua Su
    Tao Sun
    Meng Li
    Yuan Xia
    Mingying Li
    Dongmei Wang
    Fei Lu
    Jingjing Ye
    Chunyan Ji
    Journal of Translational Medicine, 20
  • [25] B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry
    Sundin, Andrew
    Grzywacz, Bartosz J.
    Yohe, Sophia
    Linden, Michael A.
    Courville, Elizabeth L.
    HUMAN PATHOLOGY, 2017, 61 : 140 - 147
  • [26] Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients
    Wu, H
    Wasik, MA
    Przybylski, G
    Finan, J
    Haynes, B
    Moore, H
    Leonard, DGB
    Montone, KT
    Naji, A
    Nowell, PC
    Kamoun, M
    Tomaszewski, JE
    Salhany, KE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (04) : 487 - 496
  • [27] Abnormal proportions and functions of myeloid-derived suppressor cells in peripheral blood of patients with diffuse large B-cell lymphoma
    Jingru Liu
    Shucheng Chen
    Yanrong Huang
    Kaiming Xu
    Maoqing Tan
    Wei Dai
    Xiaoting Wang
    Diyu Hou
    Shuxia Zhang
    Jiadi Chen
    Huifang Huang
    BMC Cancer, 25 (1)
  • [28] Diffuse large B-cell lymphoma remodels the fibroblastic reticular network that acquires aberrant immunosuppressive capabilities; implications for the regulation of anti-tumor immunity in the immuno-oncology era.
    Apollonio, B.
    Jarvis, P.
    Phillips, E.
    Kuhnl, A.
    Salisbury, J.
    Zacharioudakis, G.
    Sutton, L. -A.
    Rosenquist, R.
    Jarrett, R.
    Amini, R. -M.
    Vardi, A.
    Ramsay, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 26 - 26
  • [29] CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion
    Hu, Quan-Quan
    Wen, Zhao-Feng
    Huang, Qi-Tang
    Li, Qian
    Zhai, Zhi-Min
    Li, Yan-Li
    LABORATORY INVESTIGATION, 2022, 102 (12) : 1377 - 1388
  • [30] Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
    Winter, Allison
    Rybicki, Lisa
    Shah, Shetal N.
    Jagadeesh, Deepa
    Gerds, Aaron T.
    Hamilton, Betty K.
    Liu, Hien
    Dean, Robert
    Sobecks, Ronald
    Pohlman, Brad
    Smith, Mitchell
    Kalaycio, Matt
    Bolwell, Brian J.
    Majhail, Navneet S.
    Hill, Brian T.
    LEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1195 - 1201